These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17510395

  • 1. Mitochondrial genetic background modifies breast cancer risk.
    Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ.
    Cancer Res; 2007 May 15; 67(10):4687-94. PubMed ID: 17510395
    [Abstract] [Full Text] [Related]

  • 2. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer.
    Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN.
    Cancer Lett; 2007 May 08; 249(2):249-55. PubMed ID: 17081685
    [Abstract] [Full Text] [Related]

  • 3. Association of common PALB2 polymorphisms with breast cancer risk: a case-control study.
    Chen P, Liang J, Wang Z, Zhou X, Chen L, Li M, Xie D, Hu Z, Shen H, Wang H.
    Clin Cancer Res; 2008 Sep 15; 14(18):5931-7. PubMed ID: 18794107
    [Abstract] [Full Text] [Related]

  • 4. Mitochondrial DNA haplogroups: role in the prevalence and severity of knee osteoarthritis.
    Rego-Pérez I, Fernández-Moreno M, Fernández-López C, Arenas J, Blanco FJ.
    Arthritis Rheum; 2008 Aug 15; 58(8):2387-96. PubMed ID: 18668590
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer.
    Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, Luben R, Redman K, Munday H, Easton DF, Dunning AM, Ponder BA.
    Cancer Res; 2006 Jan 15; 66(2):1225-33. PubMed ID: 16424062
    [Abstract] [Full Text] [Related]

  • 7. SNPs in ultraconserved elements and familial breast cancer risk.
    Yang R, Frank B, Hemminki K, Bartram CR, Wappenschmidt B, Sutter C, Kiechle M, Bugert P, Schmutzler RK, Arnold N, Weber BH, Niederacher D, Meindl A, Burwinkel B.
    Carcinogenesis; 2008 Feb 15; 29(2):351-5. PubMed ID: 18174240
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer.
    Kotsopoulos J, Zhang WW, Zhang S, McCready D, Trudeau M, Zhang P, Sun P, Narod SA.
    Breast Cancer Res Treat; 2008 Dec 15; 112(3):585-93. PubMed ID: 18204969
    [Abstract] [Full Text] [Related]

  • 12. p53 Alterations and protein accumulation in benign breast tissue and breast cancer risk: a cohort study.
    Rohan TE, Li SQ, Hartwick R, Kandel RA.
    Cancer Epidemiol Biomarkers Prev; 2006 Jul 15; 15(7):1316-23. PubMed ID: 16835330
    [Abstract] [Full Text] [Related]

  • 13. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL.
    Cancer Epidemiol Biomarkers Prev; 2008 May 15; 17(5):1082-7. PubMed ID: 18483329
    [Abstract] [Full Text] [Related]

  • 14. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A, Mohamed AO, Kamal H, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A.
    Ann N Y Acad Sci; 2008 Sep 15; 1138():84-94. PubMed ID: 18837888
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
    Willems P, Claes K, Baeyens A, Vandersickel V, Werbrouck J, De Ruyck K, Poppe B, Van den Broecke R, Makar A, Marras E, Perletti G, Thierens H, Vral A.
    Genes Chromosomes Cancer; 2008 Feb 15; 47(2):137-48. PubMed ID: 18000863
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
    Wheatley-Price P, Asomaning K, Reid A, Zhai R, Su L, Zhou W, Zhu A, Ryan DP, Christiani DC, Liu G.
    Cancer; 2008 Mar 01; 112(5):1037-42. PubMed ID: 18205184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.